In this video, David L. Wirta, MD, presents: "Tear Volume and Tear Total Lipid Concentration Following Administration of Acoltremon 0.003%".

Data from the pivotal COMET clinical trials reveal how the first topical ocular neuromodulator approved for DED—TRYPTYR (acoltremon ophthalmic solution) 0.003%—delivers a rapid and lasting increase…

In this video, Eric Papas, PhD, presents “Dry eye disease in diabetic neuropathy and its management with Systane Hydration.”